An engineered antibody-interleukin-12 fusion protein with enhanced tumor vascular targeting properties.
Int J Cancer. 2006 Nov 1;119(9):2205-12. doi: 10.1002/ijc.22101.
Int J Cancer. 2006.
PMID: 16823838
Free article.